Alosetron

Category: Irritable Bowel Syndrome

Alosetron, sold under the brand name Lotronex among others, is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It was patented in 1987 and approved for medical use in 2002.[1] It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002... [wikipedia]

Dosage List

Alosetron Hydrochloride .5 mg Oral Tablet
NDC: 0054-0295
Labeler:
Roxane Laboratories, Inc.
Alosetron Hydrochloride 1 mg Oral Tablet
NDC: 0054-0296
Labeler:
Roxane Laboratories, Inc.
Alosetron Hydrochloride .5 mg Oral Tablet, Film Coated
NDC: 42291-123
Labeler:
Avkare, Inc.
Alosetron Hydrochloride 1 mg Oral Tablet, Film Coated
NDC: 42291-124
Labeler:
Avkare, Inc.
Alosetron Hydrochloride .5 mg Oral Tablet
NDC: 45963-479
Labeler:
Actavis Pharma, Inc.
Alosetron Hydrochloride 1 mg Oral Tablet
NDC: 45963-480
Labeler:
Actavis Pharma, Inc.
Alosetron Hydrochloride .5 mg Oral Tablet
NDC: 49884-819
Labeler:
Par Pharmaceutical, Inc.
Alosetron Hydrochloride 1 mg Oral Tablet
NDC: 49884-820
Labeler:
Par Pharmaceutical, Inc.
Alosetron Hydrochloride .5 mg Oral Tablet, Film Coated
NDC: 53746-248
Labeler:
Amneal Pharmaceuticals of New York LLC
Alosetron Hydrochloride 1 mg Oral Tablet, Film Coated
NDC: 53746-249
Labeler:
Amneal Pharmaceuticals of New York LLC
More Results

Related Brands

Drugs with the same active ingredients